Venture capital firms that fund cancer companies. 47 records carry it: 47 companies.
Related tags
47 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
5AM Ventures San Francisco, CA, US A venture firm with offices in San Francisco and Boston that funds early-stage drug companies and also runs a public-market fund. Its cancer investments include the cell therapy company Artiva, the protein degrader pioneer Arvinas and Enliven Therapeutics. | none | none | none | ||
Andera Partners Paris, FR A Paris private equity firm whose life sciences team, through its BioDiscovery funds, invests in European and US drug and medtech companies. Its life sciences portfolio includes the cancer T-cell therapy company T-Knife. | none | none | none | ||
Andreessen Horowitz Bio + Health Menlo Park, CA, US The life sciences and healthcare arm of the Silicon Valley venture firm Andreessen Horowitz (a16z). It backs founders who mix biology, software and care delivery, including a small number of cancer drug and diagnostics start-ups. | none | none | none | ||
ARCH Venture Partners Chicago, IL, US A Chicago venture firm that starts and funds science-heavy biotech companies. Several of its companies work on cancer drugs, cancer cell therapies and cancer diagnostics. | none | none | none | ||
Atlas Venture Cambridge, MA, US A Cambridge, Massachusetts biotech-only venture firm that seeds and incubates new drug companies. Cancer companies it has built include Bicycle Therapeutics, Day One Biopharmaceuticals and Antares Therapeutics. | none | none | none | ||
Bain Capital Life Sciences Boston, MA, US The life sciences investing arm of Bain Capital in Boston. It funds later-stage private and public biotech companies, including cancer drug developers such as Olema Oncology, Nuvalent, Revolution Medicines and Mersana. | none | none | none | ||
Boxer Capital San Diego, CA, US A San Diego biotech investment firm that backs precision medicine companies from private rounds through public listing. Its venture highlights include cancer drug developers Mirati, G1 Therapeutics, Tango and Elevation Oncology. | none | none | none | ||
Casdin Capital New York, NY, US A New York investment firm founded by Eli Casdin that invests in life sciences companies on both public and private markets. Its venture list includes cancer companies such as Black Diamond Therapeutics and Function Oncology. | none | none | none | ||
Cormorant Asset Management Boston, MA, US A Boston biotech investment firm led by Bihua Chen that invests in private and public life sciences companies and is a frequent name in crossover rounds. Its website could not be reached at the time of research. | none | none | none | ||
DCVC Palo Alto, CA, US DCVC, once Data Collective, is a deep-tech venture firm whose DCVC Bio arm backs computational biology and cancer diagnostics companies. | none | none | none | ||
Deerfield Management New York, NY, US A New York healthcare investment firm that funds companies, runs its own drug discovery labs and a philanthropy arm. It founded and seeded Nuvalent, a lung cancer drug company that GSK agreed to buy for $10.6 billion. | none | none | none | ||
EcoR1 Capital San Francisco, CA, US EcoR1 Capital is a San Francisco investment fund that only invests in biotech, from private rounds to listed companies, and often leads the crossover financings of cancer drug developers. | none | none | none | ||
EQT Life Sciences Amsterdam, NL The life sciences venture arm of the Swedish investment group EQT, formerly the Amsterdam firm LSP (Life Sciences Partners). It funds European and US biotech and medtech companies, including in cancer. | none | none | none | ||
Even One Ventures United States (head office not published), US Even One Ventures is a venture studio that builds companies in the image of one patient's playbook: Sid Sijbrandij, the GitLab co-founder who, told in 2024 that he had run out of options for recurrent osteosarcoma, assembled a team, pursued every diagnostic and built individualised treatments in parallel. | none | none | patient-first, venture-studio | ||
F-Prime Capital Cambridge, MA, US F-Prime Capital is the venture firm that grew out of Fidelity's own money. It invests in healthcare and technology companies, including cancer diagnostics and therapeutics, from seed to growth. | none | none | none | ||
Flagship Pioneering Cambridge, MA, US A Cambridge, Massachusetts firm that invents and builds its own biotech companies rather than backing outside founders. Its cancer-focused companies include Foghorn Therapeutics and Repertoire Immune Medicines. | none | none | none | ||
Forbion Naarden, NL A Dutch venture firm that funds European and North American biotech companies from formation to late-stage growth. Its homepage says it manages around EUR 5 billion across 11 funds. | none | none | none | ||
Foresite Capital San Francisco, CA, US A San Francisco investment firm that funds healthcare companies at every stage with a data-science approach. Its cancer investments include CG Oncology, ALX Oncology, Kura Oncology and the blood-test company Delfi Diagnostics. | none | none | none | ||
Founders Fund San Francisco, CA, US Peter Thiel's San Francisco venture firm, best known for SpaceX, Palantir and Anduril. Its public portfolio page does not name any cancer companies, so its relevance to oncology is limited. | none | none | none | ||
Frazier Life Sciences Seattle, WA, US A life sciences venture firm that grew out of Frazier Healthcare Partners in Seattle and now operates independently, backing private and public biotech companies. | none | none | none | ||
General Catalyst Cambridge, MA, US A large venture firm founded in Cambridge, Massachusetts, that now spans seed to growth and even owns a hospital system. Its health portfolio includes the radiopharmaceutical company Alpha-9 Oncology and the radiology AI firm Aidoc. | none | none | none | ||
Gilde Healthcare Utrecht, NL Gilde Healthcare is a Dutch investor with separate funds for venture-stage health companies and for established healthcare businesses, backing diagnostics, medical technology and therapeutics across Europe and the United States. | none | none | none | ||
Jeito Capital Paris, FR Jeito Capital is a Paris fund that writes large cheques for European biotech companies so they can take drugs through late-stage trials without selling early. Cancer medicines are a recurring theme. | none | none | none | ||
Khosla Ventures Menlo Park, CA, US Vinod Khosla's Menlo Park venture firm, which backs bold early-stage technology companies including health and biology start-ups. Cancer-related bets include the blood-test company Guardant Health and the AI oncology start-up Radical Health. | none | none | none | ||
Lightspeed Venture Partners Menlo Park, CA, US Lightspeed is a large Silicon Valley venture firm best known for software, whose health practice backs cancer diagnostics, AI drug discovery and digital oncology companies. | none | none | none | ||
Logos Capital San Francisco, CA, US Logos Capital is a San Francisco healthcare investment firm that backs biotech companies from private rounds through their public life, and turns up repeatedly in cancer drug financings. | none | none | none | ||
Longwood Fund Boston, MA, US Longwood Fund is a Boston venture firm that founds and funds early biotech companies, several of them in cancer. | none | none | none | ||
Lux Capital New York, NY, US A New York venture firm that backs deep technology companies, from defence and AI to biology. Its biotech holdings include the AI drug discovery company Recursion and the imaging-based drug hunter Eikon Therapeutics. | none | none | none | ||
Medicxi London, GB A London and Geneva venture firm that funds single-asset drug companies run by experienced drug hunters. Its cancer companies have included ProfoundBio (bought by Genmab), Kurome Therapeutics and Gadeta. | none | none | none | ||
MPM BioImpact Boston, MA, US A Boston biotech investor, formerly MPM Capital, that builds and funds companies and runs an Oncology Impact Fund that donates part of its profits to cancer research. It built Aktis Oncology and backs Cullinan Oncology and Tizona. | none | none | none | ||
Novo Holdings Hellerup, DK The investment company of the Novo Nordisk Foundation, based near Copenhagen. It is one of the largest life science investors in the world and its venture portfolio includes cancer companies such as Myricx Bio, which Novartis agreed to buy. | none | none | none | ||
Omega Funds Boston, MA, US A Boston and Geneva venture firm that invests in medicines across oncology, immunology and rare disease. Its impact page lists cancer products it helped bring to patients, including the lung cancer drug Ibtrozi and the colorectal screening test Epi proColon. | none | none | none | ||
OrbiMed New York, NY, US OrbiMed is a New York healthcare investment firm managing about 20 billion dollars across venture, private equity, public equity and royalty strategies, with teams in North America, Europe and Asia. Its cancer portfolio includes Adcendo (antibody-drug conjugates), Adela (blood-based cancer detection), Adicet Bio (immune-cell therapies) and Alterome (alteration-specific drugs). | none | none | none | ||
Perceptive Advisors New York, NY, US Perceptive Advisors is a New York healthcare investment firm founded by Joseph Edelman in 1999 that runs a public-market fund, a credit fund and, through Xontogeny, a venture fund backing seed and Series A biotech companies from preclinical work to clinical proof of concept. It is one of the most frequent crossover investors in oncology IPOs. | none | none | none | ||
Polaris Partners Boston, MA, US A Boston venture firm with a long record of co-founding biotech companies with academic scientists such as Bob Langer. Its cancer companies include Syros Pharmaceuticals, Kronos Bio and the blood-test company Freenome. | none | none | none | ||
RA Capital Management Boston, MA, US A Boston investment firm that funds biotech companies both privately and on the stock market, and incubates its own. Its cancer bets include Aktis Oncology, CG Oncology and Bicara Therapeutics. | none | none | none | ||
Samsara BioCapital Palo Alto, CA, US A Palo Alto life sciences investment firm founded by Srinivas Akkaraju that invests in private and public biotech companies. Its website could not be read at the time of research. | none | none | none | ||
Sante Ventures Austin, TX, US Sante Ventures is an Austin, Texas healthcare venture firm that invests early in medical devices, diagnostics, biotech and health technology, including cancer companies. | none | none | none | ||
Section 32 (S32) San Diego, CA, US Section 32 is a venture firm founded by the former head of Google Ventures that invests across biology, healthcare and computing, including AI-native cancer diagnostics and therapeutics companies. | none | none | none | ||
Sofinnova Partners Paris, FR One of Europe's oldest life sciences venture firms, based in Paris. It has backed cancer companies such as Innate Pharma, Crescendo Biologics and Hookipa, and its portfolio company Myricx was bought by Novartis. | none | none | none | ||
SR One London, GB SR One is a transatlantic biotech venture firm that began as GSK's corporate venture arm and now invests independently from London and the US West Coast. Oncology accounts for a large share of its portfolio, including Akamis Bio (gene-based immunotherapy), Avenzo Therapeutics, Charm Therapeutics (menin inhibitors for acute myeloid leukaemia) and Biotheryx (protein degradation). | none | none | none | ||
SV Health Investors London, GB A London and Boston healthcare investor with 30 years of history that runs biotech, medtech and growth funds, including a dementia fund. Its biotech portfolio includes cancer companies such as Bicycle Therapeutics and Xilio Therapeutics. | none | none | none | ||
TCGX (TCG Crossover) San Francisco Bay Area, CA, US TCGX is a crossover fund: it invests in private biotech companies in the round or two before they list, then keeps holding the shares as public investors. Several cancer drug developers in OnCo raised from it. | none | none | none | ||
Third Rock Ventures Boston, MA, US Third Rock Ventures builds biotech companies from scratch around a scientific idea, then funds and staffs them. Several of the best-known precision oncology companies of the last fifteen years started in its offices. | none | none | none | ||
Venrock Palo Alto, CA, US The Rockefeller family's venture firm, formed in 1969, which invests in technology and healthcare companies from its Palo Alto and New York offices. Its website could not be read without JavaScript. | none | none | none | ||
Versant Ventures San Francisco, CA, US A San Francisco life sciences venture firm that builds biotech companies in its own laboratories in North America and Europe. It created the radiopharmaceutical company RayzeBio and backed Gritstone, Repare and Abdera. | none | none | none | ||
Vida Ventures Boston, MA, US Vida Ventures is a life sciences venture firm founded by scientists, physicians and investors that creates and funds biotech companies, often with partners such as MPM. Oncology dominates its portfolio: Aktis Oncology (radiopharmaceuticals), Adcendo (antibody-drug conjugates), Allogene (off-the-shelf CAR-T) and Halda Therapeutics, sold to Johnson & Johnson. | none | none | none |
